In these diverse and dynamic markets, adaptation is not a strategy; it is a prerequisite for thriving. Success requires a fundamental shift in mindset: walking away is rarely an option, and profitability depends on establishing a hyper-agile ... Read more
Net sales increase organically by +5.2% to € 5.3 billion; foreign exchange effects of –4.9%, portfolio effects of +0.7% EBITDA pre grows organically by +8.8% to € 1.7 billion; foreign exchange effects of... Read more
Reports third quarter 2025 total revenue of $7.8 million, representing 3% growth compared to the third quarter of 2024. Third quarter 2025 recurring revenue, which includes consumables and annual service contracts, increased 32% compared ... Read more
Argonaut Manufacturing Services, a leading contract development manufacturing organization (CDMO) specializing in aseptic drug product manufacturing and the manufacturing of life science and diagnostic products announces the appointment of Ric... Read more
Net sales increase organically by +5.2% to € 5.3 billion; foreign exchange effects of –4.9%, portfolio effects of +0.7% EBITDA pre grows organically by +8.8% to € 1.7 billion; foreign exchange effects of... Read more
Launched its first Asia office to support biotech and healthtech innovation and collaboration within the region The Asia office will house the Angelini Ventures Global Intelligence Hub, leveraging its proprietary AI-powered platform and global n... Read more
Collaboration will investigate how continuous flow cellular engineering and donor-to-dose manufacturing expertise may advance scalable, non-viral processes for next-generation cell therapies. Kytopen Corp., a leader in continuous flow cellul... Read more
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotechnology company focused on the discovery and development of fully human antibodies, announced the formation of a strategic partnership. ... Read more
© 2025 Biopharma Boardroom. All Rights Reserved.
